Dr Kerry Cheong 520 South Road, Kurralta Park, South Australia 5037

Welcome to Dr Kerry Cheong, a renowned medical oncologist located at Kurralta Park, South Road, 520, in Australia. Dr Cheong is affiliated with the prestigious Icon Cancer Centre Adelaide, where she has been providing exceptional healthcare services since March 2005.

Dr Kerry Cheong is a highly trained and experienced doctor, having obtained her Bachelor of Medicine and Bachelor of Surgery (MBBS) with honors from Flinders University. She further honed her skills by completing her specialist oncology training at Guy's Hospital in London, where she actively participated in phase II trials of new drugs and conducted research in the areas of quality of life and geriatric oncology.

With her extensive clinical experience, Dr Cheong is well-versed in managing a wide range of solid tumor malignancies. However, she has a special clinical interest in breast cancer, lung cancer, and gastrointestinal cancer. Her expertise in these areas allows her to provide personalized and comprehensive care to her patients, ensuring they receive the best possible treatment options tailored to their specific needs.

At Dr Kerry Cheong's institution, patients can expect to receive the highest standard of care in a compassionate and supportive environment. Dr Cheong is committed to staying at the forefront of medical advancements and utilizes the latest evidence-based practices to deliver optimal outcomes for her patients.

In addition to her clinical work, Dr Kerry Cheong is actively involved in research and has contributed to numerous medical publications. She remains dedicated to advancing the field of oncology and improving patient outcomes through ongoing research and participation in clinical trials.

If you or a loved one are seeking expert medical oncology services, look no further than Dr Kerry Cheong. With her expertise, compassionate approach, and affiliation with Icon Cancer Centre Adelaide, she is committed to providing the best possible care for patients facing cancer. Contact Dr Kerry Cheong's institution today to schedule a consultation and take the first step towards a healthier future.

Please note that the mentioned clinical trial, "A Phase II, Multicenter, Randomized, Double-Blind Study of RO7247669 Combined with Nab-Paclitaxel compared with Pembrolizumab Combined with Nab-Paclitaxel in Participants with Previously Untreated PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer," showcases Dr Cheong's dedication to advancing treatment options and improving outcomes for breast cancer patients.